CureVac Shares Are Soaring Because the Company Won’t Give Up on a Covid-19 Vaccine

CureVac Shares Are Soaring Because the Company Won’t Give Up on a Covid-19 Vaccine
·3 min read

The CEO of the German company said on Thursday that CureVac hoped its vaccine candidate could still be of use after trial data showed it was a failure.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting